Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-011575
Filing Date
2022-03-24
Accepted
2022-03-24 08:30:47
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-10k_20211231.htm   iXBRL 10-K 2661859
2 EX-4.7 apvo-ex47_128.htm EX-4.7 23975
3 EX-10.6 apvo-ex106_519.htm EX-10.6 163407
4 EX-21.1 apvo-ex211_9.htm EX-21.1 6015
5 EX-23.1 apvo-ex231_12.htm EX-23.1 8833
6 EX-31.1 apvo-ex311_11.htm EX-31.1 20684
7 EX-31.2 apvo-ex312_13.htm EX-31.2 21139
8 EX-32.1 apvo-ex321_10.htm EX-32.1 10354
9 EX-32.2 apvo-ex322_6.htm EX-32.2 10408
10 GRAPHIC g5potoq1tzbl000001.jpg GRAPHIC 317482
11 GRAPHIC g5potoq1tzbl000002.jpg GRAPHIC 75999
12 GRAPHIC g5potoq1tzbl000003.jpg GRAPHIC 62863
  Complete submission text file 0001564590-22-011575.txt   10674866

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA apvo-20211231.xsd EX-101.SCH 71507
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20211231_cal.xml EX-101.CAL 63995
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20211231_def.xml EX-101.DEF 224379
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20211231_lab.xml EX-101.LAB 523495
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20211231_pre.xml EX-101.PRE 411447
81 EXTRACTED XBRL INSTANCE DOCUMENT apvo-10k_20211231_htm.xml XML 1409974
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 22764766
SIC: 2834 Pharmaceutical Preparations